Skip to main content
. 2022 Feb 25;83(2):331–343. doi: 10.3348/jksr.2021.0173

Fig. 2. Coupled forest plots of sensitivity and specificity of the LI-RADS Treatment Response (A) and mRECIST viable category (B) for diagnosing viable hepatocellular carcinoma.

Fig. 2

CI = confidence interval, LI-RADS = Liver Imaging Reporting and Data Systems, mRECIST = modified Response Evaluation Criteria in Solid Tumors